14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients

<div>The flowchart of the development and validation of the methylation-based signature for HCC (MSH). LASSO: least absolute shrinkage and selection operator.</div>

BioMed Research International

fig1

Figure 1

Figure 1: 14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients 